nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR8—hematopoietic system—thymus cancer	0.0581	0.187	CbGeAlD
Imiquimod—Basal cell carcinoma—Octreotide—thymus cancer	0.0442	0.0641	CcSEcCtD
Imiquimod—TLR8—lymphoid tissue—thymus cancer	0.0409	0.132	CbGeAlD
Imiquimod—TLR8—bone marrow—thymus cancer	0.0373	0.12	CbGeAlD
Imiquimod—TLR7—hematopoietic system—thymus cancer	0.0367	0.118	CbGeAlD
Imiquimod—TLR8—lung—thymus cancer	0.0338	0.109	CbGeAlD
Imiquimod—Ischaemia—Octreotide—thymus cancer	0.0285	0.0414	CcSEcCtD
Imiquimod—Rectal tenesmus—Octreotide—thymus cancer	0.0279	0.0405	CcSEcCtD
Imiquimod—TLR7—lymphoid tissue—thymus cancer	0.0258	0.083	CbGeAlD
Imiquimod—TLR8—lymph node—thymus cancer	0.0231	0.0743	CbGeAlD
Imiquimod—Hernia—Octreotide—thymus cancer	0.0222	0.0322	CcSEcCtD
Imiquimod—Proctalgia—Octreotide—thymus cancer	0.0222	0.0322	CcSEcCtD
Imiquimod—TLR7—lung—thymus cancer	0.0213	0.0685	CbGeAlD
Imiquimod—Rectal disorder—Octreotide—thymus cancer	0.0212	0.0308	CcSEcCtD
Imiquimod—Anorectal disorder—Octreotide—thymus cancer	0.0198	0.0287	CcSEcCtD
Imiquimod—Anorectal discomfort—Octreotide—thymus cancer	0.019	0.0276	CcSEcCtD
Imiquimod—Local reaction—Octreotide—thymus cancer	0.0188	0.0273	CcSEcCtD
Imiquimod—Pregnancy—Octreotide—thymus cancer	0.0183	0.0266	CcSEcCtD
Imiquimod—Influenza-like symptoms—Octreotide—thymus cancer	0.0146	0.0211	CcSEcCtD
Imiquimod—TLR7—lymph node—thymus cancer	0.0146	0.0468	CbGeAlD
Imiquimod—Herpes zoster—Octreotide—thymus cancer	0.0138	0.0201	CcSEcCtD
Imiquimod—Otitis media—Octreotide—thymus cancer	0.0134	0.0194	CcSEcCtD
Imiquimod—Tingling sensation—Octreotide—thymus cancer	0.0129	0.0188	CcSEcCtD
Imiquimod—Stinging—Octreotide—thymus cancer	0.0128	0.0186	CcSEcCtD
Imiquimod—Viral infection—Octreotide—thymus cancer	0.0115	0.0167	CcSEcCtD
Imiquimod—Herpes simplex—Octreotide—thymus cancer	0.0113	0.0164	CcSEcCtD
Imiquimod—Vaginal inflammation—Octreotide—thymus cancer	0.0104	0.0151	CcSEcCtD
Imiquimod—Influenza like illness—Octreotide—thymus cancer	0.0101	0.0147	CcSEcCtD
Imiquimod—Vaginal infection—Octreotide—thymus cancer	0.00982	0.0143	CcSEcCtD
Imiquimod—Nasal congestion—Octreotide—thymus cancer	0.00829	0.012	CcSEcCtD
Imiquimod—Injury—Octreotide—thymus cancer	0.00822	0.0119	CcSEcCtD
Imiquimod—Arthritis—Octreotide—thymus cancer	0.00777	0.0113	CcSEcCtD
Imiquimod—Pain in extremity—Octreotide—thymus cancer	0.00755	0.011	CcSEcCtD
Imiquimod—Irritability—Octreotide—thymus cancer	0.00721	0.0105	CcSEcCtD
Imiquimod—CYP1A2—hematopoietic system—thymus cancer	0.0066	0.0212	CbGeAlD
Imiquimod—Influenza—Octreotide—thymus cancer	0.00653	0.00947	CcSEcCtD
Imiquimod—Sweating increased—Octreotide—thymus cancer	0.00636	0.00923	CcSEcCtD
Imiquimod—Bronchitis—Octreotide—thymus cancer	0.00628	0.00911	CcSEcCtD
Imiquimod—Dysuria—Octreotide—thymus cancer	0.0061	0.00886	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Octreotide—thymus cancer	0.00607	0.0088	CcSEcCtD
Imiquimod—Depression—Octreotide—thymus cancer	0.0058	0.00842	CcSEcCtD
Imiquimod—Neuropathy peripheral—Octreotide—thymus cancer	0.0057	0.00828	CcSEcCtD
Imiquimod—Conjunctivitis—Octreotide—thymus cancer	0.00566	0.00821	CcSEcCtD
Imiquimod—Urinary tract infection—Octreotide—thymus cancer	0.00566	0.00821	CcSEcCtD
Imiquimod—Hepatobiliary disease—Octreotide—thymus cancer	0.0055	0.00799	CcSEcCtD
Imiquimod—Sinusitis—Octreotide—thymus cancer	0.00546	0.00792	CcSEcCtD
Imiquimod—Rhinitis—Octreotide—thymus cancer	0.00524	0.0076	CcSEcCtD
Imiquimod—Pharyngitis—Octreotide—thymus cancer	0.00519	0.00753	CcSEcCtD
Imiquimod—Visual impairment—Octreotide—thymus cancer	0.00503	0.00731	CcSEcCtD
Imiquimod—Tinnitus—Octreotide—thymus cancer	0.00487	0.00707	CcSEcCtD
Imiquimod—Flushing—Octreotide—thymus cancer	0.00485	0.00704	CcSEcCtD
Imiquimod—CYP3A4—hematopoietic system—thymus cancer	0.00478	0.0154	CbGeAlD
Imiquimod—Immune system disorder—Octreotide—thymus cancer	0.00472	0.00685	CcSEcCtD
Imiquimod—Arrhythmia—Octreotide—thymus cancer	0.00467	0.00677	CcSEcCtD
Imiquimod—Alopecia—Octreotide—thymus cancer	0.00462	0.0067	CcSEcCtD
Imiquimod—Mental disorder—Octreotide—thymus cancer	0.00458	0.00664	CcSEcCtD
Imiquimod—Malnutrition—Octreotide—thymus cancer	0.00455	0.0066	CcSEcCtD
Imiquimod—Erythema—Octreotide—thymus cancer	0.00455	0.0066	CcSEcCtD
Imiquimod—Back pain—Octreotide—thymus cancer	0.0044	0.00638	CcSEcCtD
Imiquimod—CYP1A2—thyroid gland—thymus cancer	0.00422	0.0136	CbGeAlD
Imiquimod—Ill-defined disorder—Octreotide—thymus cancer	0.00422	0.00612	CcSEcCtD
Imiquimod—Agitation—Octreotide—thymus cancer	0.00418	0.00607	CcSEcCtD
Imiquimod—Malaise—Octreotide—thymus cancer	0.0041	0.00595	CcSEcCtD
Imiquimod—Syncope—Octreotide—thymus cancer	0.00408	0.00592	CcSEcCtD
Imiquimod—Palpitations—Octreotide—thymus cancer	0.00402	0.00583	CcSEcCtD
Imiquimod—Loss of consciousness—Octreotide—thymus cancer	0.004	0.0058	CcSEcCtD
Imiquimod—Cough—Octreotide—thymus cancer	0.00397	0.00576	CcSEcCtD
Imiquimod—Convulsion—Octreotide—thymus cancer	0.00394	0.00572	CcSEcCtD
Imiquimod—Hypertension—Octreotide—thymus cancer	0.00393	0.0057	CcSEcCtD
Imiquimod—Arthralgia—Octreotide—thymus cancer	0.00387	0.00562	CcSEcCtD
Imiquimod—Chest pain—Octreotide—thymus cancer	0.00387	0.00562	CcSEcCtD
Imiquimod—Myalgia—Octreotide—thymus cancer	0.00387	0.00562	CcSEcCtD
Imiquimod—Anxiety—Octreotide—thymus cancer	0.00386	0.0056	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00385	0.00558	CcSEcCtD
Imiquimod—CYP1A2—lung—thymus cancer	0.00384	0.0123	CbGeAlD
Imiquimod—Discomfort—Octreotide—thymus cancer	0.00383	0.00555	CcSEcCtD
Imiquimod—Dry mouth—Octreotide—thymus cancer	0.00379	0.0055	CcSEcCtD
Imiquimod—Oedema—Octreotide—thymus cancer	0.00371	0.00539	CcSEcCtD
Imiquimod—Infection—Octreotide—thymus cancer	0.00369	0.00535	CcSEcCtD
Imiquimod—Shock—Octreotide—thymus cancer	0.00365	0.0053	CcSEcCtD
Imiquimod—Nervous system disorder—Octreotide—thymus cancer	0.00364	0.00528	CcSEcCtD
Imiquimod—Tachycardia—Octreotide—thymus cancer	0.00362	0.00526	CcSEcCtD
Imiquimod—Skin disorder—Octreotide—thymus cancer	0.00361	0.00523	CcSEcCtD
Imiquimod—Hyperhidrosis—Octreotide—thymus cancer	0.00359	0.00521	CcSEcCtD
Imiquimod—Anorexia—Octreotide—thymus cancer	0.00354	0.00513	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00338	0.00491	CcSEcCtD
Imiquimod—Insomnia—Octreotide—thymus cancer	0.00336	0.00487	CcSEcCtD
Imiquimod—Paraesthesia—Octreotide—thymus cancer	0.00333	0.00484	CcSEcCtD
Imiquimod—Dyspnoea—Octreotide—thymus cancer	0.00331	0.0048	CcSEcCtD
Imiquimod—Somnolence—Octreotide—thymus cancer	0.0033	0.00479	CcSEcCtD
Imiquimod—Dyspepsia—Octreotide—thymus cancer	0.00327	0.00474	CcSEcCtD
Imiquimod—Decreased appetite—Octreotide—thymus cancer	0.00323	0.00468	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Octreotide—thymus cancer	0.0032	0.00465	CcSEcCtD
Imiquimod—Fatigue—Octreotide—thymus cancer	0.0032	0.00464	CcSEcCtD
Imiquimod—Pain—Octreotide—thymus cancer	0.00317	0.00461	CcSEcCtD
Imiquimod—Feeling abnormal—Octreotide—thymus cancer	0.00306	0.00444	CcSEcCtD
Imiquimod—Gastrointestinal pain—Octreotide—thymus cancer	0.00304	0.0044	CcSEcCtD
Imiquimod—Urticaria—Octreotide—thymus cancer	0.00295	0.00428	CcSEcCtD
Imiquimod—Abdominal pain—Octreotide—thymus cancer	0.00293	0.00426	CcSEcCtD
Imiquimod—Body temperature increased—Octreotide—thymus cancer	0.00293	0.00426	CcSEcCtD
Imiquimod—Hypersensitivity—Octreotide—thymus cancer	0.00273	0.00397	CcSEcCtD
Imiquimod—Asthenia—Octreotide—thymus cancer	0.00266	0.00386	CcSEcCtD
Imiquimod—Pruritus—Octreotide—thymus cancer	0.00263	0.00381	CcSEcCtD
Imiquimod—Diarrhoea—Octreotide—thymus cancer	0.00254	0.00369	CcSEcCtD
Imiquimod—Dizziness—Octreotide—thymus cancer	0.00245	0.00356	CcSEcCtD
Imiquimod—Vomiting—Octreotide—thymus cancer	0.00236	0.00343	CcSEcCtD
Imiquimod—Rash—Octreotide—thymus cancer	0.00234	0.0034	CcSEcCtD
Imiquimod—Dermatitis—Octreotide—thymus cancer	0.00234	0.00339	CcSEcCtD
Imiquimod—Headache—Octreotide—thymus cancer	0.00233	0.00337	CcSEcCtD
Imiquimod—Nausea—Octreotide—thymus cancer	0.0022	0.0032	CcSEcCtD
